Sisram Medical (HKSE:01696) FCF Margin % : 16.35% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Sisram Medical FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Sisram Medical's Free Cash Flow for the six months ended in Dec. 2023 was HK$240 Mil. Sisram Medical's Revenue for the six months ended in Dec. 2023 was HK$1,466 Mil. Therefore, Sisram Medical's FCF Margin % for the quarter that ended in Dec. 2023 was 16.35%.

As of today, Sisram Medical's current FCF Yield % is 14.29%.

The historical rank and industry rank for Sisram Medical's FCF Margin % or its related term are showing as below:

HKSE:01696' s FCF Margin % Range Over the Past 10 Years
Min: -11.93 Med: 10.23 Max: 21.82
Current: 9.83

During the past 10 years, the highest FCF Margin % of Sisram Medical was 21.82%. The lowest was -11.93%. And the median was 10.23%.

HKSE:01696's FCF Margin % is ranked better than
79.81% of 832 companies
in the Medical Devices & Instruments industry
Industry Median: -7.45 vs HKSE:01696: 9.83

Sisram Medical FCF Margin % Historical Data

The historical data trend for Sisram Medical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sisram Medical FCF Margin % Chart

Sisram Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

10.30

10.16

9.99

-11.93

9.84

Sisram Medical Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial													6.27	5.01	-28.35	2.73	16.35

Competitive Comparison of Sisram Medical's FCF Margin %

For the Medical Devices subindustry, Sisram Medical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sisram Medical's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sisram Medical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Sisram Medical's FCF Margin % falls into.

Sisram Medical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Sisram Medical's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	276.217	/	2805.999
	=	9.84 %

Sisram Medical's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	239.604	/	1465.673
	=	16.35 %

Sisram Medical FCF Margin % Related Terms

Thank you for viewing the detailed overview of Sisram Medical's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sisram Medical (HKSE:01696) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sisram Medical Ltd (HKSE:01696) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

HaHarash Street 18, Ofek Building 15, Industrial Park, Caesarea, ISR, 3079895

Website

https://www.sisram-medical.com

Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Harmony, and ClearLift. It operates through the following geographical segments: Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa.

Sisram Medical (HKSE:01696) Headlines

No Headlines